Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL5097732 | 0.96 | CYP19A1 (0.42) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL4406722 | 0.87 | CA1 (0.50) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL5316852 | 0.86 | BLM (0.41) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL27707944 | 0.84 | CYP19A1 (0.36) | CYP19A1ALDH1A1ACHECHRNB2CHRNA4 | |
| SCHEMBL16047302 | 0.83 | CA1 (0.46) | CA1CA12CA2CA9CYP19A1 | |
| SCHEMBL6322048 | 0.83 | RARB (0.41) | CYP19A1ALDH1A1TDP1ACHELMNA | |
| SCHEMBL5472684 | 0.83 | RARB (0.41) | CYP19A1ALDH1A1TDP1ACHELMNA | |
| SCHEMBL28508202 | 0.83 | RARB (0.41) | CYP19A1ALDH1A1TDP1ACHELMNA | |
| SCHEMBL30423398 | 0.83 | RARB (0.41) | CYP19A1ALDH1A1TDP1ACHELMNA | |
| SCHEMBL30424069 | 0.83 | RARB (0.41) | CYP19A1ALDH1A1TDP1ACHELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116444466-B | Banana aroma compound, preparation method thereof and banana essence | 万普森香料(深圳)有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-117821135-A | Multi-effect diesel oil detergent meeting cleaning performance requirement of direct injection diesel engine and preparation method thereof | 中国石油天然气股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-116478744-A | Multi-effect complexing agent suitable for ethanol diesel | 中国石油天然气股份有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-116444466-A | Banana aroma compound, preparation method thereof and banana essence | 深圳市华加生物科技有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-116444466-B | Banana aroma compound, preparation method thereof and banana essence | 万普森香料(深圳)有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-116444466-B | Banana aroma compound, preparation method thereof and banana essence | 万普森香料(深圳)有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-117821135-A | Multi-effect diesel oil detergent meeting cleaning performance requirement of direct injection diesel engine and preparation method thereof | 中国石油天然气股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-116478744-A | Multi-effect complexing agent suitable for ethanol diesel | 中国石油天然气股份有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-116444466-A | Banana aroma compound, preparation method thereof and banana essence | 深圳市华加生物科技有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-116444466-A | Banana aroma compound, preparation method thereof and banana essence | 深圳市华加生物科技有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-112240239-A | Compression ignition internal combustion engine using reactive agent | 周氏（北京）汽车技术有限公司 | 2021-01-19 | — | — | CN | disclosed |
| CN-109310601-A | Spices material | 高砂香料工业株式会社 | 2019-02-05 | — | — | CN | disclosed |
| US-20180043279-A1 | SEPARATION SYSTEMS AND METHODS OF USING THEM | QUINLAN GEORGE L (US) | 2018-02-15 | — | — | US | disclosed |
| US-9604153-B1 | Separation systems and methods of using them | Quinlan Properties, LLC (US) | 2017-03-28 | — | — | US | disclosed |
| EP-1221439-B1 | TETRAHYDROQUINOLINE DERIVATIVES | KAKEN PHARMA CO LTD (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-7037919-B1 | Tetrahydroquinoline derivatives | KAKEN PHARMACEUTICAL CO. LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| US-6777427-B2 | SPECIFIC AND STRONG BINDING AFFINITY FOR ANDROGEN RECEPTORS AND EXHIBIT ANDROGEN RECEPTOR AGONISM OR ANTAGONISM | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20030216428-A1 | Tetrahydroquinoline compounds | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2003-11-20 | — | — | US | disclosed |
| EP-1325914-A1 | TETRAHYDROQUINOLINE COMPOUNDS | Kaken Pharmaceutical Co., Ltd. (JP) | 2003-07-09 | — | — | EP | disclosed |
| EP-1221439-A1 | TETRAHYDROQUINOLINE DERIVATIVES | Kaken Pharmaceutical Co., Ltd. (JP) | 2002-07-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216428-A1 | Tetrahydroquinoline compounds | AR, MUSK, NR5A1 | CA1 4619/4885CA12 4854/4885CA2 3072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.